Mead Johnson Nutrition Co 4

Accession 0001104659-17-039523

CIK 0001452575operating

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 3:47 PM ET

Size

48.6 KB

Accession

0001104659-17-039523

Insider Transaction Report

Form 4

Period: 2017-06-15

Mead Johnson Nutrition CoMJN

Jakobsen Peter Kasper

President, Americas

Transactions

Disposition to Issuer
Performance Shares
2017-06-15$90.00/sh−34,680$3,121,200→ 0 total
→ Common Stock (34,680 underlying)
Disposition to Issuer
Common Stock
2017-06-15$90.00/sh−67,524$6,077,160→ 0 total
Disposition to Issuer
Restricted Stock Units
2017-06-15$90.00/sh−13,530$1,217,700→ 0 total
→ Common Stock (13,530 underlying)
Disposition to Issuer
Restricted Stock Units
2017-06-15$90.00/sh−18,568$1,671,120→ 0 total
→ Common Stock (18,568 underlying)
Disposition to Issuer
Restricted Stock Units
2017-06-15−46,801→ 0 total
→ Common Stock (46,801 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$43.70/sh−17,409$760,773→ 0 total
Exercise: $46.30Exp: 2020-02-24→ Common Stock (17,409 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$16.24/sh−125,581$2,039,435→ 0 total
Exercise: $73.76Exp: 2026-02-28→ Common Stock (125,581 underlying)
Award
Performance Shares
2017-06-15+25,277→ 34,680 total
→ Common Stock (25,277 underlying)
Disposition to Issuer
Restricted Stock Units
2017-06-15$90.00/sh−14,427$1,298,430→ 0 total
→ Common Stock (14,427 underlying)
Disposition to Issuer
Restricted Stock Units
2017-06-15−31,201→ 0 total
→ Common Stock (31,201 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$63.42/sh−27,341$1,733,966→ 0 total
Exercise: $26.58Exp: 2019-03-11→ Common Stock (27,341 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$31.14/sh−23,469$730,825→ 0 total
Exercise: $58.86Exp: 2021-03-02→ Common Stock (23,469 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$11.74/sh−24,558$288,311→ 0 total
Exercise: $78.26Exp: 2022-03-02→ Common Stock (24,558 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$15.35/sh−64,364$987,987→ 0 total
Exercise: $74.65Exp: 2023-02-27→ Common Stock (64,364 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$8.45/sh−73,649$622,334→ 0 total
Exercise: $81.55Exp: 2024-02-28→ Common Stock (73,649 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2017-06-15$16.24/sh−118,500$1,924,440→ 0 total
Exercise: $73.76Exp: 2026-02-28→ Common Stock (118,500 underlying)
Award
Performance Shares
2017-06-15+9,020→ 15,731 total
→ Common Stock (9,020 underlying)
Disposition to Issuer
Performance Shares
2017-06-15$90.00/sh−15,731$1,415,790→ 0 total
→ Common Stock (15,731 underlying)

Footnotes (23)

[F1]Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc ("RB"), and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
[F10]One-fourth of this stock option was scheduled to vest on each of the first, second, third and fourth anniversaries of the March 11, 2009 grant date.
[F11]Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option.
[F12]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 24, 2010 grant date.
[F13]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the March 2, 2011 grant date.
[F14]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the March 2, 2012 grant date.
[F15]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 27, 2013 grant date.
[F16]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2014 grant date.
[F17]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 29, 2016 grant date.
[F18]One-fourth of this stock option was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 29, 2016 grant date.
[F19]Each performance share ("PSU") represents the contingent right to receive one share of common stock.
[F2]Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.
[F20]Represents the target number of PSUs for any one year performance period not yet completed as of the effective time of the Merger to which the reporting person became entitled on an accelerated basis pursuant to the Merger Agreement at the effective time of the Merger.
[F21]These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018.
[F22]Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed.
[F23]These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019.
[F3]Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.
[F4]This RSU was originally scheduled to vest on February 28, 2018.
[F5]This RSU was originally scheduled to vest on February 26, 2019.
[F6]This RSU was originally scheduled to vest on February 29, 2020.
[F7]One-third of this RSU was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2017 grant date. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger.
[F8]The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination.
[F9]This RSU was originally scheduled to vest on February 28, 2020. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination.

Documents

1 file

4
a4.xmlPrimary
4

Issuer

Mead Johnson Nutrition Co

CIK 0001452575

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001452575

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 3:47 PM ET
Size: 48.6 KB

View on SEC.gov